GxP adds statistical analysis support to portfolio

Published: 23-Dec-2009

GxP Consulting, a provider of consultancy services to the pharmaceutical, biopharmaceutical and healthcare industries with offices in the UK and US, has added statistical analysis support for clinical data assessment to its GCP compliance and clinical technology support portfolio.

GxP Consulting, a provider of consultancy services to the pharmaceutical, biopharmaceutical and healthcare industries with offices in the UK and US, has added statistical analysis support for clinical data assessment to its GCP compliance and clinical technology support portfolio.

Timothy Haley, data analyst and SAS programmer, will lead the new statistical analysis support service. He has previously worked for Novartis, Glaxo Group Research, Wyeth Research (UK), the European Commission and Serono.

Mark Stevens, managing director of GxP Consulting, said the new team would help clients to manage the clinical trials process from specification through to project closure and eSubmission.

You may also like